TABLE 2.
Rank | Gene | Location | Category | TCGA Tumors
|
TCGA on-malignant
|
Spore Tumors
|
EDRN/Canary Tumors | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
LUAD | LUSC | P-value | LUAD | LUSC | LUAD | LUSC | |||||
1 | SPATA16 | 3q26.31 | A | 2.09 | 3.31 | 3.1E-77 | 2.01 | 2.01 | 2.08 | 3.38 | 1.98 |
| |||||||||||
2 | USP13 | 3q26.2-q26.3 | A | 2.07 | 3.36 | 6.32E-76 | 2.01 | 2.01 | 2.20 | 3.54 | 1.99 |
| |||||||||||
3 | TPRG1 | 3q28 | A | 2.05 | 3.09 | 7.29E-85 | 2.01 | 2.01 | 2.17 | 3.51 | 1.96 |
| |||||||||||
4 | ZMAT3 | 3q26.32 | A | 2.07 | 3.39 | 6.76E-73 | 2.00 | 2.01 | 2.20 | 3.54 | 2.00 |
| |||||||||||
5 | MFN1 | 3q26.33 | A | 2.07 | 3.36 | 9.98E-74 | 2.01 | 2.01 | 2.20 | 3.54 | 2.00 |
| |||||||||||
6 | HTR3D | 3q27.1 | A | 2.07 | 3.45 | 8.75E-67 | 2.01 | 2.01 | 2.14 | 3.36 | 2.01 |
| |||||||||||
7 | ABCF3 | 3q27.1 | A | 2.06 | 3.40 | 1.34E-71 | 2.01 | 2.01 | 2.14 | 3.36 | 2.03 |
| |||||||||||
8 | ABCC5 | 3q27 | A | 2.06 | 3.45 | 1.86E-66 | 2.01 | 2.01 | 2.14 | 3.36 | 2.01 |
| |||||||||||
9 | VWA5B2 | 3q27.1 | A | 2.06 | 3.38 | 1.19E-72 | 2.01 | 2.01 | 2.18 | 3.53 | 2.11 |
| |||||||||||
10 | FLJ42393 | 3q27.3 | A | 2.05 | 3.14 | 1.58E-81 | 2.01 | 2.02 | 2.17 | 3.51 | 2.02 |
| |||||||||||
11 | ADIPOQ | 3q27 | A | 2.05 | 3.17 | 4.87E-80 | 2.01 | 2.01 | 2.17 | 3.51 | 2.00 |
| |||||||||||
12 | RTP2 | 3q27.3 | A | 2.05 | 3.14 | 4.58E-81 | 2.01 | 2.01 | 2.17 | 3.51 | 1.99 |
| |||||||||||
13 | SST | 3q28 | A | 2.05 | 3.14 | 4.58E-81 | 2.01 | 2.01 | 2.17 | 3.51 | 1.99 |
| |||||||||||
14 | YEATS2 | 3q27.1 | A | 2.06 | 3.49 | 5.64E-59 | 2.01 | 2.01 | 2.18 | 3.53 | 2.01 |
| |||||||||||
15 | LOC100131635 | 3q27.3 | A | 2.05 | 3.14 | 6.37E-81 | 2.01 | 2.01 | 2.17 | 3.51 | 1.97 |
| |||||||||||
16 | PPP1R2 | 3q29 | A | 2.06 | 3.08 | 2.35E-85 | 2.01 | 2.01 | 1.93 | 2.90 | 2.06 |
| |||||||||||
17 | OSTN | 3q28 | A | 2.05 | 3.09 | 2.14E-83 | 2.01 | 2.02 | 2.17 | 3.51 | 1.99 |
| |||||||||||
18 | SERPINI2 | 3q26.1 | A | 2.11 | 3.20 | 8.5E-78 | 2.01 | 2.01 | 2.08 | 3.49 | 1.98 |
| |||||||||||
19 | PDCD10 | 3q26.1 | A | 2.11 | 3.20 | 3.22E-77 | 2.01 | 2.01 | 2.08 | 3.49 | 1.98 |
| |||||||||||
20 | PIK3CA | 3q26.3 | A&B | 2.07 | 3.17 | 1.55E-78 | 2.01 | 2.01 | 2.20 | 3.54 | 1.98 |
| |||||||||||
21 | SOX2 | 3q26.3-q27 | B | 2.07 | 3.45 | 7.48E-57 | 2.01 | 2.01 | 2.24 | 3.65 | 2.02 |
| |||||||||||
22 | STIM2 | 4p15.2 | A | 2.04 | 1.79 | 3.12E-25 | 2.01 | 2.01 | 1.96 | 1.66 | 2.08 |
| |||||||||||
23 | TBC1D19 | 4p15.2 | A | 2.04 | 1.79 | 3.83E-25 | 2.01 | 2.01 | 2.0 | 1.85 | 2.08 |
| |||||||||||
24 | RBPJ | 4p15.2 | A | 2.04 | 1.80 | 4.34E-18 | 2.01 | 2.02 | 1.98 | 1.75 | 2.08 |
25 | C6orf203 | 6q21 | A | 1.83 | 2.07 | 1.15E-06 | 2.01 | 2.01 | 1.88 | 2.12 | 1.87 |
26 | HACE1 | 6q16.3 | A | 1.82 | 2.06 | 1.32E-06 | 2.01 | 2.02 | 1.86 | 2.10 | 1.86 |
27 | BVES | 6q21 | A | 1.82 | 2.07 | 1.24E-06 | 2.01 | 2.01 | 1.88 | 2.12 | 1.86 |
28 | ALKBH7 | 19p13.3 | A | 1.81 | 1.95 | 4.88E-18 | 2.01 | 2.01 | 1.87 | 1.95 | 2.18 |
| |||||||||||
29 | C9orf53 | 9p21.3 | A | 1.75 | 1.59 | 7.27E-08 | 2.01 | 2.01 | 1.79 | 1.67 | 2.04 |
30 | CLPP | 19p13.3 | A | 1.81 | 1.95 | 4.88E-18 | 2.01 | 2.01 | 1.87 | 1.95 | 2.18 |
31 | MIR1233-2 | 15q14 | A | 1.80 | 1.95 | 5.25E-12 | 1.94 | 1.97 | 2.33 | 2.30 | 1.88 |
| |||||||||||
32 | NKX2-6 | 8p21.2 | A | 1.81 | 1.74 | 0.10E-03 | 2.01 | 2.01 | 1.85 | 1.69 | 1.92 |
33 | SIGLEC14 | 19q13.32 | A | 1.80 | 1.94 | 5.04E-06 | 1.88 | 1.90 | 1.91 | 2.13 | 2.19 |
• Rank: ranked by the coefficients to the classification model. P-value is obtained by the two-tailed t-test between copy numbers of LUADs and LUSCs.
• There are no LUSC samples in EDRN/Canary dataset.
• For convenience, CNVs of TCGA dataset were transformed back to the regular copy number format (2 × 2CNV).
• Category A: Genes selected by multivariate classification methods; Category B: Proved tumor associated genes for lung cancer;